Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study

References

• Askling J, Dickman P, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356–1362.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357–359.
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–459.
   PubMed Web of Science ®Google Scholar
• Soetikno R, Lin O, Heidenreich P, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48–54.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287–1297.
   PubMed Web of Science ®Google Scholar
• ECCO. Guidelines Ulcerative Colitis (UC) Consensus Part 1 and 2; 2016.
   Google Scholar
• ECCO. Guidelines Crohn´s Disease (CD) Consensus Part 1 and 2; 2016.
   Google Scholar
• Centre for Clinical Practice at NICE (UK). Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas. 2011. http://www.nice.org.uk/.
   Google Scholar
• Annese V, Beaugerie L, Egan L, et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015;9:945–965.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Cai T, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015;13:322–329.
   PubMed Web of Science ®Google Scholar
• Lofthus E. Jr. Does monitoring prevent cancer in inflammatory bowel disease? J Clin Gastroenterol. 2003;36(5 Suppl):S79–S83.
   Google Scholar
• Velayos F, Liu L, Lewis J, et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology. 2010;139:1511–1518.
   PubMed Web of Science ®Google Scholar
• Vienne A, Simon T, Cosnes J, et al. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther. 2011;34:188–195.
   PubMed Web of Science ®Google Scholar
• Mooiweer E, van der Meulen-de Jong A, Ponsioen C, et al. Incidence of interval colorectal cancer among inflammatory bowel disease patients undergoing regular colonoscopic surveillance. Clin Gastroenterol Hepatol. 2015;13:1656–1661.
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767.
   PubMed Web of Science ®Google Scholar
• Kloor M, Staffa L, Ahadova A, et al. Clinical significance of microsatellite instability in colorectal cancer. Langenbecks Arch Surg. 2014;399:23–28.
   PubMed Web of Science ®Google Scholar
• Loh K, Chia JA, Greco S, et al. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosom Cancer. 2008;47:449–460.
   PubMed Web of Science ®Google Scholar
• Melotte V, Lentjes MH, van den Bosch SM, et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst. 2009;101:916–927.
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015;149:1204–1225.
   PubMed Web of Science ®Google Scholar
• You J, Jones P. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell. 2012;22:9–20.
   PubMed Web of Science ®Google Scholar
• Kisiel JB, Yab TC, Nazer Hussain FT, et al. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:546.
   PubMed Web of Science ®Google Scholar
• Kisiel JBKG, Piscitello AJ, Chandra T, et al. Stool DNA analysis is cost-effective for colorectal cancer surveillance in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2016;S1542-3565:30439–30436.
   Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41:1037–1043.
   PubMed Web of Science ®Google Scholar
• Moum B, Vain MH, Ekbom A, et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion. 1995;56:377–381.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Geboes K, Riddell R, O¨st A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404–409.
   PubMed Web of Science ®Google Scholar
• Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–968.
   PubMed Web of Science ®Google Scholar
• Hiraoka S, Kato J, Nakarai A, et al. Consecutive measurements by faecal immunochemical test in quiescent ulcerative colitis patients can detect clinical relapse. J Crohns Colitis. 2016;10:687–694.
   PubMed Web of Science ®Google Scholar
• Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2013;11:1313–1318.
   PubMed Web of Science ®Google Scholar
• Redwood DG, Asay ED, Blake ID, et al. Stool DNA testing for screening detection of colorectal neoplasia in Alaska Native People. Mayo Clin Proc. 2016;91:61–70.
   PubMed Web of Science ®Google Scholar
• Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–799.
   PubMed Web of Science ®Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–1105.
   PubMed Web of Science ®Google Scholar
• Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis. 2006;12:205–211.
   PubMed Web of Science ®Google Scholar
• Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079–1083.
   PubMed Web of Science ®Google Scholar
• Söderlund S, Brandt L, Lapidus A, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–1567.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Jegadeesan R, Gutierrez NG, et al. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. J Crohns Colitis. 2013;7:684–691.
   PubMedGoogle Scholar
• Ullman T, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311–1139.
   PubMed Web of Science ®Google Scholar
• Venkatesh PG, Jegadeesan R, Gutierrez NG, et al. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis. 2013;7:968–973.
   PubMed Web of Science ®Google Scholar
• Goldstone R, Itzkowitz S, Harpaz N, et al. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc. 2011;74:1087–1093.
   PubMed Web of Science ®Google Scholar
• Choi CH, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110:1461–1471.
   PubMed Web of Science ®Google Scholar
• Johnson D, Taylor W, Aboelsoud M, et al. DNA methylation and mutation of small colonic neoplasms in ulcerative colitis and crohn's colitis: implications for surveillance. Inflamm Bowel Dis. 2016;22:1559–1567.
   PubMed Web of Science ®Google Scholar
• van Rijn A, Fockens P, Siersema PD, et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn’s colitis patients in the Netherlands. World J Gastroenterol. 2009;15:226–230.
   PubMed Web of Science ®Google Scholar
• Xiang L, Zhan Q, Zhao XH, et al. Risk factors associated with missed colorectal flat adenoma: a multicenter retrospective tandem colonoscopy study. World J Gastroenterol. 2014;20:10927–10937.
   PubMed Web of Science ®Google Scholar
• Hurlstone D, Sanders D, Lobo AJ, et al. Indigo carmine-assisted high magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005;37:1186–1192.
   PubMed Web of Science ®Google Scholar
• Subramanian V, Mannath J, Ragunath K, et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:304–312.
   PubMed Web of Science ®Google Scholar
• Cotter TG, Burger KN, Devens ME, et al. Long-term follow-up of patients having false positive multi-target stool DNA tests after negative screening colonoscopy: the LONG-HAUL Cohort Study. Cancer Epidemiol Biomarkers Prev. 2017;26:614–621.
   PubMed Web of Science ®Google Scholar
• Hovde Ø, Høivik ML, Henriksen M, et al. Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study. J Crohns Colitis. 2017;11:571–577.
   PubMed Web of Science ®Google Scholar
• Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.
   PubMed Web of Science ®Google Scholar